CORAL SPRINGS, Fla.--(BUSINESS WIRE)--Point-of-Care Partners, a leading health information technology (HIT) strategy and management consulting firm, has expanded the ePrescribing State Law Review to encompass emerging state mandates related to the dispensing of opiates and biosimilars drugs.
“States are passing sweeping changes to address the opiate crisis and to help ensure biosimilars are optimally dispensed to patients,” said Tony Schueth, CEO and Managing Partner at Point-of-Care Partners (POCP). “These new mandates are focused on delivering the right information to the point of care and require EHRs to accommodate new forms of communication between prescribers, pharmacies and Prescription Drug Monitoring Programs.”
Recent Legislation Impacting EHRs
- Mandatory Electronic Prescribing: 2 states have mandated electronic prescribing for controlled substances (EPCS) and others have introduced legislation for eRx mandates.
- Prescription Drug Monitoring Programs: 26 states now require prescribers to check PDMPs and 3 have proposed legislation to require the State to make access available to prescriber systems (via EHRs). One state has made the bold move of requiring all prescriptions, including non-controlled substances, to be submitted to the PDMP effective January 2018.
- Opiate Dispensing Notification: 1 state has passed legislation that places new limits on prescriptions for opiates and requires pharmacies to notify prescribers when a lesser amount is dispensed versus what was prescribed.
- Biosimilars: 19 states have enacted legislation requiring physicians to be notified via their EHRs when a biosimilar substitution is made – and 8 more have pending legislation.
About Point-of-Care Partners
Point-of-Care Partners is a health IT management consulting firm with in-depth expertise in ePrescribing, eMedication management, health information exchange, accountable care organizations, multi-stakeholder initiatives and other programs requiring health IT project management.